| Health / Medical Topics |
Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8
A radioimmunoconjugate containing the murine IgG1 anti-CD45 monoclonal antibody (MoAb) BC8 labeled with yttrium 90 (Y90), with potential immunotherapeutic activity. Yttrium Y 90 anti-CD45 monoclonal antibody BC8 binds to CD45 antigen, a receptor protein-tyrosine phosphatase expressed on the surface of both normal and malignant hematopoietic cells. After binding and internalization by CD45-expressing tumor cells, this agent may deliver a cytotoxic dose of beta radiation. (NCI Thesaurus)
YOU MAY ALSO LIKE
A radioimmunoconjugate comprised of the monoclonal antibody AHN-12 conjugated to the radioisotope yttrium 90 with potential radioimmunotherapeutic activity. Yttrium Y 90 monoclonal…
A radioimmunoconjugate consisting of the murine IgG1 anti-CD19 monoclonal antibody (MoAb) BU12 labeled with the beta-emitting radioisotope yttrium Y 90 with radioisotopic…
A radioactive form of the rare metal yttrium that is used in radiation therapy to treat some types of tumors. Yttrium Y…
A murine monoclonal antibody directed against the CD5 antigen and labeled with Yttrium-90, a beta-emitting radioisotope. CD5 is a type-I transmembrane glycoprotein…
A metal of the rare earth group of elements. A radioactive form of yttrium may be attached to a monoclonal antibody or…
Human YTHDF2 wild-type allele is located in the vicinity of 1p35 and is approximately 33 kb in length. This allele, which encodes…
